4 ms·
(Note: didn't read the article, just the HN comments.) "I don't disagree about the cruelty of putting people in the control group. You're basically denying the
by hga 16y ago
(Note: didn't read the article, just the HN comments.)
"I don't disagree about the cruelty of putting people in the control group. You're basically denying them medicine that they need."
The problem is, you don't know this until you do the trial.
I'm not up on current figures, but sometime ago a read that the efficacy of placebos in treating organic (i.e. very real and physical) heart damage was 50% plus or minus a bit (I think it was plus). (Given all the connections we know of between the nervous system and things in the body that could allow this the finding was not entirely surprising.)
They aren't entirely heartless, so to speak: sometimes they will stop trials involving life or death conditions and start giving everyone the new drug if the initial results are fantastic enough and they've got enough control evidence (including how populations not in the study have responded to the old treatment(s)).
And there are enough phase 3 (efficacy) trial failures it's clear we have to do this; the alternatives are worse.
There's also the "first do no harm" rule, which I'd argue is in alignment with this process. Giving someone a new drug that's worse than existing treatments is harmful and one sad fact of side effects is that by definition the more rare they are, the more people you'll have to give the drug to to be able to find them. At each level, phases 1, 2, 3 and general marketing you expose it to larger populations, which is the only way to find out :-(.